UF Health Cancer Center - Orlando Health recognized as one of America's Best Breast Centers

NewsGuard 100/100 Score

UF Health Cancer Center - Orlando Health earns the 2015 Women's Choice Award as one of America's Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment. Breast cancer is the second most common form of cancer among American women according to the American Cancer Society, and one in eight women in the U.S. will develop invasive breast cancer during their lifetime.

By carrying the evidence-based designation of the Women's Choice Award seal, UF Health Cancer Center - Orlando Health has signified its commitment to a global mission to elevate the patient experience for women and all patients as one of more than 315 America's Best Breast Centers.

"Every 2 minutes a women in the U.S. is diagnosed with breast cancer, and she needs to know which breast centers she can trust to navigate this uncertain path," says Delia Passi, CEO & founder of WomenCertified, home of the Women's Choice Award. "Breast care is extremely vital to women's health and we want them to know that UF Health Cancer Center - Orlando Health has met the highest standards in caring for the needs of their female patients. The Women's Choice Award is the only program that identifies the nation's best in healthcare based on patient satisfaction, clinical excellence and what women really want when it comes to treatment and a quality medical experience."

UF Health Cancer Center - Orlando Health earned the award by having met the National Accreditation Program for Breast Centers (NAPBC) standards from the American College of Surgeons. The NAPBC is a consortium of national, professional organizations focused on breast health and dedicated to the improvement of quality care and outcomes of patients with diseases of the breast through evidence-based standards and patient and professional education. As one of America's Best Breast Centers, UF Health Cancer Center - Orlando Health also carries the Seal of the American College of Radiologists as a Breast Imaging Center of Excellence, and scored above-average on the Centers for Medicare and Medicaid Services patient satisfaction measures.

"We are very honored to receive this special recognition," says Mark Roh, MD, President, UF Health Cancer Center - Orlando Health. "Every year thousands of women walk through our doors to face the fight of their life. We understand that fight and the importance of treating the entire person - both on a clinical and emotional level. Thanks to tremendous advancements in technology and treatment, when caught early breast cancer has a more than 95% cure rate. But even if not curable, breast cancer is one of the most treatable cancers. We are proud to support the brave women who trust us with their lives and their future breast care."

The Women's Choice Award helps women and their families by providing recommendations they can trust and use when making healthcare choices.

"We have found that recommendations are the single most important consideration used by women in selecting a hospital or care center," added Passi. "By letting women know which breast centers in their area are among America's best, we are able to reduce risk by helping them make better decisions and smarter healthcare choices."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer